A clinically proven, prospective, thermal dose descriptor exists [4]

Clinical Cancer Research

Volumn 12, Issue 6, 2006, Pages 1944-1946

  Thrall, Donald E ^a   Dewhirst, Mark W ^a   Jones, Ellen L ^a   Vujaskovic, Zeljko ^a   Yu, Daohai ^a   Craciunescu, Oana I ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CELL; CATHETER; CELL DEATH; CELL HETEROGENEITY; CLINICAL TRIAL; CYTOTOXICITY; HUMAN; HYPERTHERMIA; LETTER; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SARCOMA; THERMOMETRY;

EID: 33645653588     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-2446     Document Type: Letter

References (3)

1. Thrall DE, LaRue SM, Yu D, et al. Thermal dose is related to duration of local control in canine sarcomas treated with thermoradiotherapy. Clin Cancer Res 2005;11:5206-14.
2. Jones EL, Oleson JR, Prosnitz LR, et al. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 2005;23:3079-85.
3. Sneed PK, Dewhirst MW, Samulski T, Blivin J, Prosnitz LR. Should interstitial thermometry be used for deep hyperthermia? Int J Radiat Oncol Biol Phys 1998;40:1205-12.